Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-15-001018

Options or other derivatives

  • INTERIM CEO acquired 220,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DAVIS STEPHEN INTERIM CEO 2015-03-20 Grant or award · Stock Option (right to buy) +100,000 100,000 D
DAVIS STEPHEN INTERIM CEO 2015-03-20 Grant or award · Stock Option (right to buy) +120,000 120,000 D
Loading xslF345X03/form4-03242015_020339.xml…